About the STOP Program
purpose of the STOP Program is to help reduce smoking in Ontario. To do this, STOP works toward two main goals: (1) increase access to smoking cessation aids for Ontario smokers who want to quit, and (2) enhance
capacity in health care settings to deliver comprehensive smoking
cessation treatment to patients.
the effectiveness of different ways of linking smokers across Ontario with cessation aids. Increasing
access to cessation aids means reducing the barriers to cessation medications
and counselling support. Treatment is delivered through our partners or
directly to smokers. Since 2005, over 100,000 smokers from across Ontario have received
free treatment through the STOP Program.
STOP has studied
twelve different ways of distributing free cessation medication combined with
varying levels of counselling support – ten using nicotine replacement
therapy (NRT) and two using prescription medications for smoking cessation - bupropion (Zyban®)
and varenicline (Champix®). Our research will inform the development
of policies and future smoking cessation programs.
Greater Public Health
The study will
identify the best way to deliver effective smoking cessation treatment to large numbers of smokers. Based on this knowledge healthcare policies can be
modeled to help a substantial number of smokers to quit. The rate of smoking in
steadily declined over the past 30 years, but smoking remains a primary cause
of mortality and morbidity with 18% of the general population still smoking.
replacement therapy, bupropion (Zyban®) and varenicline (Champix®) are
clinically proven medications that can double the chances of success in
quitting smoking. However, survey results indicate that less than half of those
who attempt to quit smoking use any of these medications.
distribution of these evidence-based clinical interventions has the potential to greatly reduce
the prevalence of smoking.
Program Funding and Team
The STOP Program
is lead by scientists and smoking cessation specialists at the Centre for
Addiction and Mental Health (CAMH) in Toronto,
Ontario. The team is lead by Dr.
Peter Selby, a physician and researcher at CAMH.
The STOP Program
is supported by funding from the Ontario Ministry of Health and Long-Term Care - Health Promotion Division.